Healthpeak Properties (NYSE:DOC – Get Free Report) is anticipated to announce its Q3 2025 results after the market closes on Thursday, October 23rd. Analysts expect the company to announce earnings of $0.45 per share and revenue of $681.6470 million for the quarter. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS.Investors may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Friday, October 24, 2025 at 10:00 AM ET.
Healthpeak Properties (NYSE:DOC – Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The business had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. During the same period in the prior year, the business earned $0.45 earnings per share. The business’s revenue was down .2% on a year-over-year basis. On average, analysts expect Healthpeak Properties to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Healthpeak Properties Stock Down 0.7%
Shares of NYSE:DOC opened at $18.59 on Wednesday. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. Healthpeak Properties has a 52-week low of $16.63 and a 52-week high of $23.26. The stock’s fifty day simple moving average is $18.23 and its 200-day simple moving average is $17.90. The company has a market capitalization of $12.92 billion, a P/E ratio of 77.46, a P/E/G ratio of 3.20 and a beta of 1.09.
Healthpeak Properties Dividend Announcement
Analyst Ratings Changes
Several analysts have recently issued reports on DOC shares. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research report on Monday, September 15th. Evercore ISI set a $22.00 price objective on Healthpeak Properties in a research report on Monday, September 15th. Scotiabank lowered Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and dropped their target price for the company from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wall Street Zen lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Monday, July 7th. Finally, Cantor Fitzgerald initiated coverage on Healthpeak Properties in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price for the company. Eight equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $21.33.
Check Out Our Latest Stock Report on Healthpeak Properties
Insider Buying and Selling
In other news, CEO Scott M. Brinker purchased 2,930 shares of the company’s stock in a transaction on Thursday, July 31st. The stock was bought at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the purchase, the chief executive officer directly owned 210,416 shares of the company’s stock, valued at $3,589,696.96. The trade was a 1.41% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders acquired 8,783 shares of company stock valued at $150,129 in the last ninety days. Corporate insiders own 0.23% of the company’s stock.
Institutional Investors Weigh In On Healthpeak Properties
Several institutional investors and hedge funds have recently added to or reduced their stakes in DOC. CYBER HORNET ETFs LLC acquired a new stake in Healthpeak Properties during the second quarter worth about $33,000. Binnacle Investments Inc increased its stake in Healthpeak Properties by 19.2% during the second quarter. Binnacle Investments Inc now owns 8,247 shares of the real estate investment trust’s stock worth $144,000 after acquiring an additional 1,327 shares during the last quarter. Geneos Wealth Management Inc. increased its stake in Healthpeak Properties by 18.5% during the second quarter. Geneos Wealth Management Inc. now owns 10,150 shares of the real estate investment trust’s stock worth $178,000 after acquiring an additional 1,584 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new stake in Healthpeak Properties during the second quarter worth about $218,000. Finally, Globeflex Capital L P increased its stake in Healthpeak Properties by 174.0% during the second quarter. Globeflex Capital L P now owns 20,765 shares of the real estate investment trust’s stock worth $364,000 after acquiring an additional 13,187 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
- Five stocks we like better than Healthpeak Properties
- Canada Bond Market Holiday: How to Invest and Trade
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- What Are Dividends? Buy the Best Dividend Stocks
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- What is the S&P 500 and How It is Distinct from Other Indexes
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.